Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001641172-25-001222
Filing Date
2025-03-28
Accepted
2025-03-28 16:39:37
Documents
5
Effectiveness Date
2025-03-28

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 63091
2 ex5-1.htm EX-5.1 17068
3 ex23-1.htm EX-23.1 3214
4 ex107.htm EX-FILING FEES 14257
5 ex5-1_001.jpg GRAPHIC 12254
  Complete submission text file 0001641172-25-001222.txt   115658
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286225 | Film No.: 25787034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)